Lack of Convincing Evidence of Artemisinin Resistance in India

被引:4
|
作者
Rasmussen, Charlotte [1 ]
Valecha, Neena [2 ]
Ringwald, Pascal [1 ]
机构
[1] WHO, Global Malaria Programme, Drug Efficacy & Response Unit, Geneva, Switzerland
[2] Natl Inst Med Res, New Delhi, India
关键词
D O I
10.1093/cid/ciz166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1461 / 1462
页数:3
相关论文
共 50 条
  • [41] CONVINCING EMPIRICAL EVIDENCE ON 6 MEMBER JURY
    ZEISEL, H
    DIAMOND, SS
    UNIVERSITY OF CHICAGO LAW REVIEW, 1974, 41 (02): : 281 - 295
  • [42] Reply to 'No convincing evidence for the independence of persistence and flexibility'
    Egner, Tobias
    NATURE REVIEWS PSYCHOLOGY, 2024, 3 (09): : 639 - 639
  • [43] Deciphering the signatures of artemisinin resistance
    Hastings, Ian M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (01) : 203 - 204
  • [44] Time to contain artemisinin resistance
    不详
    LANCET, 2014, 383 (9927): : 1438 - 1438
  • [45] Convincing evidence for the pumping activity of lymphatics - Reply
    Aukland, EMK
    ACTA PHYSIOLOGICA, 2006, 186 (04) : 319 - 319
  • [46] IS THERE CONVINCING EVIDENCE FOR THE EXISTENCE OF A SCHIZOPHRENIA DISEASE ENTITY
    BENTALL, RP
    BULLETIN OF THE BRITISH PSYCHOLOGICAL SOCIETY, 1986, 39 : A66 - A66
  • [47] Carcinogenicity of asbestos: Convincing evidence, conflicting interests
    Chaturvedi, S
    Chaturvedi, S
    NATIONAL MEDICAL JOURNAL OF INDIA, 2001, 14 (01): : 43 - 46
  • [48] When Lack of Evidence Is Evidence of Lack
    Neil Pickering
    Journal of Bioethical Inquiry, 2015, 12 : 545 - 547
  • [49] Spread of Artemisinin Resistance in Malaria
    Hawkes, Michael
    Conroy, Andrea L.
    Kain, Kevin C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1944 - 1945
  • [50] Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence?
    Bich-Tram Huynh
    Michael Padget
    Benoit Garin
    Perlinot Herindrainy
    Elsa Kermorvant-Duchemin
    Laurence Watier
    Didier Guillemot
    Elisabeth Delarocque-Astagneau
    BMC Infectious Diseases, 15